Bayer slides on €9.5bn loss caused by litigation, COVID-19 i...

Bayer counted the cost of its expensive Roundup weedkiller settlement in the second quarter with a €9.5 billion net loss made worse by lower sales in its pharma and consumer he

BI opens second branch of digital lab in China

Boehringer Ingelheim has announced that it will open a second branch of its digital lab, BI X, in July this year in China.

Does pharma’s future lie in China?

Healthcare innovation has a long history in effective collaboration, whether that’s across academia and industry or borders.

Vifor forges iron drug partnership with Fresenius in China

Vifor Pharma has forged a strategic partnership with Fresenius Kabi, focusing on marketing a portfolio of iron deficiency drugs.

Nine pharma trends for 2020

Sarah Rickwood looks back at how pharma changed over the last decade and what this might mean for the industry in 2020.

China’s Adagene raises $69m for cancer immunotherapies